ArticleAmerican economic journal. Economic policy2018
Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D.
Article in American economic journal. Economic policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Estimating price elasticities of demand for pain relief drugs: evidence from Medicare Part D.International journal of health economics and management · 2024Article
- The Health Costs of Cost Sharing.The quarterly journal of economics · 2024Article
- Association Between Cost-Sharing and Buprenorphine Prescription Abandonment.Journal of general internal medicine · 2024Article
- How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?American economic journal. Economic policy · 2024Article
- Article
- Why higher copayments for opioids did not reduce use among Medicare beneficiaries.Health economics · 2024Article
- Do High-Deductible Health Plans Incentivize Changing the Timing of Substance Use Disorder Treatment?Medical care research and review : MCRR · 2023Article
- How do low-income enrollees in the Affordable Care Act marketplaces respond to cost-sharing?The Journal of risk and insurance · 2023Article
- Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs.Health economics · 2023Article
- Healthcare Rationing in Public Insurance Programs: Evidence from Medicaid.American economic journal. Economic policy · 2022Article
- Changes in health care utilization and financial protection after integration of the rural and urban social health insurance schemes in Beijing, China.BMC health services research · 2022Article
- Pharmacy switching in response to preferred pharmacy networks in Medicare Part D.Health services research · 2022Article
- Effects of High-Deductible Health Plans on Enrollees With Mental Health Conditions With and Without Substance Use Disorders.Psychiatric services (Washington, D.C.) · 2022Article
- Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less.Endocrinology, diabetes & metabolism · 2021Article
- Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D.The journal of political economy · 2020Article
- Screening in Contract Design: Evidence from the ACA Health Insurance Exchanges.American economic journal. Economic policy · 2019Article
- Health Care Spending and Utilization in Public and Private Medicare.American economic journal. Applied economics · 2019Article
- Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach.International journal for equity in health · 2019Article
- Strategic Formulary Design in Medicare Part D Plans.American economic journal. Economic policy · 2018Article
- Health care demand elasticities by type of service.Journal of health economics · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We explore how private drug plans set cost-sharing in the context of Medicare Part D. While publicly-provided drug coverage typically involves uniform cost-sharing across drugs, we document substantial heterogeneity in the cost-sharing for different drugs within privately-provided plans. We also document that private plans systematically set higher consumer cost sharing for drugs or classes associated with more elastic demand; to do so we estimate price elasticities of demand across more than 150 drugs and across more than 100 therapeutic classes. We conclude by discussing the various channels that likely affect private plans' cost-sharing decisions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.